Meeting On Science Conduct Seen As A Noble Attempt That Fell Short

Meeting On Science Conduct Seen As A Noble Attempt That Fell Short Author: Franklin Hoke, pp.1 Attendees praise conveners' good intentions but say the gathering lacked substance Participants are praising last month's "Convocation on Scientific Conduct" and the meeting's hosts, National Academy of Sciences (NAS) president Bruce Alberts and Institute of Medicine (IOM) head Kenneth Shine, for placing research ethics firmly on their

Written byFranklin Hoke
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Meeting On Science Conduct Seen As A Noble Attempt That Fell Short
Author: Franklin Hoke, pp.1

Attendees praise conveners' good intentions but say the gathering lacked substance

Participants are praising last month's "Convocation on Scientific Conduct" and the meeting's hosts, National Academy of Sciences (NAS) president Bruce Alberts and Institute of Medicine (IOM) head Kenneth Shine, for placing research ethics firmly on their prestigious organizations' agendas. Some meeting critics, however, say that the conference failed to sufficiently explore specific cases or to adequately define different types of scientific misconduct.

And many of the attendees note with some dismay that active research scientists were largely absent from among the approximately 250 people present in the academy's Washington, D.C., auditorium. The meeting instead was dominated by those who are responsible for preventing or responding to scientific misconduct--university administrators, government officials, and journal editors.

Sessions at the meeting, held June 6 and 7, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies